Cannara Biotech Inc (LOVE.V)
0.75
-0.03
(-3.85%)
CAD |
TSXV |
May 27, 15:58
Cannara Biotech Profit Margin (Quarterly): -17.51% for Feb. 29, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -17.51% |
| November 30, 2023 | 10.82% |
| August 31, 2023 | 25.27% |
| May 31, 2023 | 18.49% |
| February 28, 2023 | -4.74% |
| November 30, 2022 | 0.03% |
| August 31, 2022 | 20.84% |
| May 31, 2022 | 14.30% |
| February 28, 2022 | -15.44% |
| November 30, 2021 | -8.08% |
| August 31, 2021 | 18.15% |
| Date | Value |
|---|---|
| May 31, 2021 | 23.71% |
| February 28, 2021 | -38.21% |
| November 30, 2020 | -255.5% |
| August 31, 2020 | -659.4% |
| May 31, 2020 | -310.9% |
| February 29, 2020 | -528.0% |
| November 30, 2019 | -509.9% |
| August 31, 2019 | -646.5% |
| May 31, 2019 | -504.0% |
| February 28, 2019 | -748.1% |
| November 30, 2018 | -444.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-659.4%
Minimum
Aug 2020
25.27%
Maximum
Aug 2023
-168.3%
Average
-11.76%
Median
Profit Margin (Quarterly) Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | -897.6% |
| Nova Mentis Life Science Corp | -649.3% |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.02% |
| Return on Assets | 4.46% |
| Return on Invested Capital | 5.04% |
| Gross Profit Margin (Quarterly) | 21.04% |
| Operating Margin (Quarterly) | -9.96% |
| Return on Net Operating Assets | 4.56% |